Literature DB >> 11896548

Haploidentical 'megadose' CD34+ cell transplants for patients with acute leukemia.

M F Martelli1, Y Reisner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11896548     DOI： 10.1038/sj.leu.2402382

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  7 in total

1.  Long-term results after transplantation of CD34+ selected (CellPro) versus unselected peripheral blood progenitor cells (PBPC) from related allogeneic donors.

Authors:  Hans-Georg Kopp; Stefan Wirths; Christoph Faul; Wolfgang Bethge; Stefan Scheding; Wolfram Brugger; Lothar Kanz; Wichard Vogel
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-09       Impact factor: 4.553

Review 2.  Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias.

Authors:  A Moretta; D Pende; F Locatelli; L Moretta
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

3.  Measuring T cell immunity to influenza vaccination in children after haemopoietic stem cell transplantation.

Authors:  W Nicholas Haining; John W Evans; Nilufer P Seth; G Derek Callaway; Kai W Wucherpfennig; Lee M Nadler; Eva C Guinan
Journal:  Br J Haematol       Date:  2004-11       Impact factor: 6.998

4.  Megadose CD34+ hemopoietic stem cell transplantation for patients with high risk acute myeloid leukemia who have no HLA matched donor--a pilot study of a full haplotype mismatch transplantation.

Authors:  Hee-Je Kim; Woo-Sung Min; Yoon-Hee Park; Yoo-Jin Kim; Dong-Wook Kim; Jong-Wook Lee; Chun-Choo Kim
Journal:  Korean J Intern Med       Date:  2004-12       Impact factor: 2.884

Review 5.  High-Risk Leukemia: Past, Present, and Future Role of NK Cells.

Authors:  Melissa Mavers; Alice Bertaina
Journal:  J Immunol Res       Date:  2018-04-15       Impact factor: 4.818

6.  Haploidentical Stem Cell Transplantation in Children With Hematological Malignancies Using αβ+ T-Cell Receptor and CD19+ Cell Depleted Grafts: High CD56dim/CD56bright NK Cell Ratio Early Following Transplantation Is Associated With Lower Relapse Incidence and Better Outcome.

Authors:  Miguel A Diaz; Josune Zubicaray; Blanca Molina; Lorea Abad; Ana Castillo; Elena Sebastian; Eva Galvez; Julia Ruiz; Jose Luis Vicario; Manuel Ramirez; Julian Sevilla; Marta González-Vicent
Journal:  Front Immunol       Date:  2019-10-30       Impact factor: 7.561

7.  Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults.

Authors:  Heather J Symons; Marianna Zahurak; Yilin Cao; Allen Chen; Kenneth Cooke; Christopher Gamper; Orly Klein; Nicolas Llosa; Elias T Zambidis; Richard Ambinder; Javier Bolaños-Meade; Ivan Borrello; Robert Brodsky; Amy DeZern; Ivana Gojo; Margaret Showel; Lode Swinnen; B Douglas Smith; Leo Luznik; Richard J Jones; Ephraim J Fuchs
Journal:  Blood Adv       Date:  2020-08-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.